Louise Nott

Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial

Derek J. Jonker, Louise Nott, Takayuki Yoshino et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 168 citations

Medicine, Oncology, Pharmacology +7

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial

John Chia, Eva Segelov, Yanhong Deng et al. · ˜The œLancet. Gastroenterology & hepatology · 2025 · 25 citations

Medicine, Oncology, Pharmacology +11

Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC

Michael Michael, Shane White, Ehtesham Abdi et al. · Asia-Pacific Journal of Clinical Oncology · 2014 · 15 citations

Medicine, Oncology, Pharmacology +13

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer

Vanessa Wong, Richard de Boer, Sally Baron‐Hay et al. · Clinical Breast Cancer · 2022 · 15 citations

Medicine, Oncology, Pharmacology +17